Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-10

Clinical Trial Update: Study of Tinostamustine for Adjuvant Treatment of Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

Completed EARLY Phase 1 clinical trial investigating tinostamustine as adjuvant treatment for glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tinostamustine (tinostamustine)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Glioblastoma Multiforme | EARLY_Phase 1 | Status: COMPLETED